InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Tada Hiroomi. Officer active across 1 company, notably Tyra Biosciences, Inc.. Cumulatively, 5 filings have been logged. History available since 15 March 2022. The latest transaction was filed on 15 March 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Tada Hiroomi is a declarant, with 5 filings in total. The 5 sampled filings, from 2022-09-08 to 2024-03-19, are attributions linked to Tyra Biosciences, Inc., where the listed role is Chief Medical Officer, and the largest individual amounts are EUR 21058.23143442526, EUR 11896.523499472, EUR 11609.29167242933, EUR 8269.232224506683, and EUR 4692.483957108679.